Zetia ezetimibe: Post marketing study data

In a double-blind, placebo-controlled, post-marketing study in 619 patients, 12-week treatment with Zetia plus fenofibrate significantly lowered LDL cholesterol compared to fenofibrate alone (p<0.001)...